| Gabriel P Lombard, MD | |
|
851 Governor Carlos Camacho Road, Tamuning, GU 96913-3153 | |
| (671) 300-0840 | |
| (671) 647-0832 |
| Full Name | Gabriel P Lombard |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 851 Governor Carlos Camacho Road, Tamuning, Guam |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033264072 | NPI | - | NPPES |
| 611 | Medicaid | GU | |
| M464 | Other | GU | GUAM BOARD OF MEDICAL EXAMINERS LICENSURE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | M464 (Guam) | Primary |
| Entity Name | The Doctors Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467503433 PECOS PAC ID: 3779472584 Enrollment ID: O20160602001446 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid.
International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.
Sleep-related breathing problems and chronic lack of sleep may each double the risk of a child becoming obese by age 15, according to new research from Albert Einstein College of Medicine of Yeshiva University. The good news is that both sleep problems can be corrected.
A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes weakly implicated in some common forms of epilepsy, to create a polygenic risk score.
Flamel Technologies announced today that it has achieved a clinical development milestone under the terms of its license agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to develop an extended release formulation of interferon beta-1a using the Medusa platform.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gabriel P Lombard, MD 148 Chalan Tasi, Pago Bay, Chalan Pago, GU 96910-0000 Ph: (671) 789-4638 | Gabriel P Lombard, MD 851 Governor Carlos Camacho Road, Tamuning, GU 96913-3153 Ph: (671) 300-0840 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has upheld a prior ruling by the U.S. District Court for the Eastern District of Michigan that Gemzar's method-of-use patent is invalid.
International Stem Cell Corporation and Sankara Nethralaya, announced today commencement of a collaboration to develop ISCO's "CytoCor™" stem cell-derived corneal tissue. The goal is to use CytoCor to treat corneal blindness and vision impairment. "This is one more step in ISCO's stated plan of building its portfolio of therapeutic agents through strategic alliances throughout the world," said Chairman, Ken Aldrich.
Sleep-related breathing problems and chronic lack of sleep may each double the risk of a child becoming obese by age 15, according to new research from Albert Einstein College of Medicine of Yeshiva University. The good news is that both sleep problems can be corrected.
A Cleveland Clinic-led initiative has come up with a new risk scoring system for epileptic or seizure disorders of genetic origin. The researchers summed up the risks for a very large number of genes weakly implicated in some common forms of epilepsy, to create a polygenic risk score.
Flamel Technologies announced today that it has achieved a clinical development milestone under the terms of its license agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to develop an extended release formulation of interferon beta-1a using the Medusa platform.
› Verified 5 days ago
Dr. Luis Golez Arguelles, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 590 S Marine Corps Drive, Suite 126 Gitc Building, Tamuning, GU 96913 Phone: 617-646-6354 Fax: 671-646-6362 |